EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma

Antonio Maiorano, Anna Ferrante Bannera, Chiara Lupia, Daniela Pastore, Emanuela Chiarella iD, Giovanna Lucia Piazzetta, Angelantonio Maglio iD, Alessandro Vatrella iD, Girolamo Pelaia iD, Corrado Pelaia iD

Advances in Respiratory Medicine · 2025

DOI: 10.3390/arm93050040 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Advances in Respiratory Medicine, 2025. Verfasst von Antonio Maiorano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Magna Graecia University, Viale Europa-Località Germaneto, 88100 Catanzaro, Italy. Hauptthemen laut MEDLINE: Beclomethasone, Asthma, Formoterol Fumarate, Diaphragm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Uncontrolled asthma remains a significant clinical challenge, often linked to impaired lung function and increased diaphragmatic workload. Recent studies have shown promising results using a triple inhaled therapy comprising beclomethasone dipropionate/formoterol fumarate/glycopyrronium (BDP/FF/G). This study assessed the real-world efficacy of BDP/FF/G on lung function and diaphragmatic workload in patients with uncontrolled asthma.

Methods

A prospective observational study enrolled 21 adult patients diagnosed with uncontrolled asthma despite high-dose ICS/LABA therapy. Patients underwent lung function tests and right diaphragmatic ultrasound assessments at baseline and after three months of treatment with BDP/FF/G (172/5/9 mcg, administered as two inhalations every 12 h).

Results

After three months, significant improvements were observed in FEV1 (from 57.75 ± 12.30% to 75.10 ± 18.94%, p < 0.001) and FEF25–75 (from 47.80 ± 19.23% to 75.10 ± 36.06%, p < 0.001). Additionally, during the same period, we recorded significant reductions in residual volume (from 130.10 ± 28.20% to 92.55 ± 21.18%, p < 0.001) and total airway resistance (Rtot) (from 164.60 ± 83.21% to 140.70 ± 83.25%, p < 0.05). The mean asthma control test (ACT) score increased by 5.6 points (p < 0.001), surpassing the established minimal clinically important difference (MCID) of 3 points and raising the cohort mean above the well-controlled threshold. The right diaphragmatic workload was significantly decreased, as shown by a reduction in thickening fraction (TF) (from 63.86 ± 17.67% to 40.29 ± 16.65%, p < 0.01). Correlation analysis indicated significant associations between diaphragmatic function and some lung function parameters (FEV1, FEF25–75, and Rtot).

Conclusions

In this real-world pilot, triple BDP/FF/G was linked to improvements in airflow, hyperinflation, symptoms, and a reduction in diaphragmatic thickening fraction, indicating potential physiological benefit. Due to the small sample size, single-centre design, and 3-month follow-up, these results should be viewed as hypothesis-generating and need to be confirmed in larger, controlled, multicentre studies with longer follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BeclomethasoneAsthmaFormoterol FumarateDiaphragmGlycopyrrolateAnti-Asthmatic AgentsHumansFemaleMaleProspective StudiesMiddle AgedAdultRespiratory Function TestsUltrasonographyTreatment OutcomeAdministration, InhalationDrug Combinations

Stichwörter der Autor:innen

diaphragmatic functioninhaled therapylung functionsmall airway diseasethoracic ultrasounduncontrolled asthma

Substanzen

BeclomethasoneFormoterol FumarateGlycopyrrolateAnti-Asthmatic AgentsDrug Combinations

Autor:innen und Institutionen

  • Department of Health Sciences, Magna Graecia University, Viale Europa-Località Germaneto, 88100 Catanzaro, Italy.
  • Department of Medical and Surgical Sciences, Magna Graecia University, Viale Europa-Località Germaneto, 88100 Catanzaro, Italy.
  • Department of Medicine, Surgery and Dentistry, University of Salerno, 84084 Salerno, Italy.

ORCID-Profile: Emanuela Chiarella, Angelantonio Maglio, Alessandro Vatrella, Girolamo Pelaia, Corrado Pelaia

Zitieren

APA

Maiorano, A., Ferrante Bannera, A., Lupia, C., Pastore, D., Chiarella, E., Piazzetta, G. L., Maglio, A., Vatrella, A., Pelaia, G., & Pelaia, C. (2025). Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma. Advances in Respiratory Medicine. https://doi.org/10.3390/arm93050040

Vancouver

Maiorano A, Ferrante Bannera A, Lupia C, Pastore D, Chiarella E, Piazzetta GL, et al. Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma. Advances in Respiratory Medicine. 2025. doi:10.3390/arm93050040

BibTeX
@article{Maiorano2025,
  author = {Maiorano, Antonio and Ferrante Bannera, Anna and Lupia, Chiara and Pastore, Daniela and Chiarella, Emanuela and Piazzetta, Giovanna Lucia and Maglio, Angelantonio and Vatrella, Alessandro and Pelaia, Girolamo and Pelaia, Corrado},
  title = {Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma},
  journal = {Advances in Respiratory Medicine},
  year = {2025},
  doi = {10.3390/arm93050040}
}
Kostenlos starten →